A new study finds that nearly two-thirds of older drivers with cognitive impairments continue to get behind the wheel, putting them at an increased risk of an auto accident.
A new study warns that Aduhelm and Leqembi, new Alzheimer's disease drugs, may cause brain shrinkage which accelerates the condition instead of treating it.
A House report raises questions about the overly-close relationship between the FDA and Biogen, which led to approval of the Alzheimer's disease drug Aduhelm, despite significant evidence the drug did…
The FDA has rejected an application to approve Nuplazid to treat Alzheimer's disease psychosis.
A new study finds that Roundup weed killer's active ingredient, glyphosate, passes through the blood-brain barrier, potentially increasing the risk of Alzheimer's and other neurodegenerative diseases.
A new study links combination hormone therapy for women going through menopause with an increased risk of Alzheimer's disease.
A new study warns that the use of antipsychotics and some Alzheimer's disease drugs can increase the risk of elderly falls and fractures.
A new study warns that the FDA fails to rely on previous experience in dealing with the approval of drugs with questionable effectiveness, which could erode public trust.
Two powerful House committee chairs are calling on the FDA to provide a raft of information on how and why it approved the controversial new Alzheimer's drug Aduhelm.
The FDA's Acting Commissioner has asked the Office of the Inspector General to investigate the agency's controversial decision to approve the new Alzheimer's disease drug, Aduhelm, following a wave of…
